CTOs on the Move

Optical Xpressions Inc

www.kyotoeyewear.com

 
Optical Xpressions Inc is a Ronkonkoma, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Hardric Laboratories Inc

Hardric Laboratories Inc is a North Chelmsford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Reliable Medical Supply

Reliable Medical Supply is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SyntheMed

SyntheMed is a Iselin, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GenMark Diagnostics

In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the Board. In 2009, a collaboration between Dr. Kayyem and Christopher Gleeson began. The two redefined the company strategy, and brought in a new board of directors, executive leadership team, and commercial management. In 2010, the company known at that time as Osmetech, was named GenMark Diagnostics and listed on NASDAQ. Mr. Gleeson remained an integral part of GenMark`s growth in the years that followed, serving as Chairman of the Board until his retirement in 2014. Dr. Kayyem currently serves as SVP, Research and Development.

Advanced Instrument Development Inc

Advanced Instrument Development Inc is a Downers Grove, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.